no effects were obtained if the b chain treatment followed inoculation of untreated or antibody-coated cells , suggesting that systemically administered b chain is capable of gaining access to and activating antibody-ricin a chain conjugates bound to the surface of syngeneic sarcoma cells in lung or subcutaneous sites .
C0007634
cells
C0699040
surface of